###begin article-title 0
###xml 129 137 <span type="species:ncbi:9606">patients</span>
Identification of four novel cytochrome P4501B1 mutations (p.I94X, p.H279D, p.Q340H, and p.K433K) in primary congenital glaucoma patients
###end article-title 0
###begin title 1
Purpose
###end title 1
###begin p 2
###xml 195 201 195 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 282 288 282 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 306 314 <span type="species:ncbi:9606">patients</span>
Primary congenital glaucoma (PCG) is an autosomal recessive eye disorder that is postulated to result from developmental defects in the anterior eye segment. Mutations in the cytochrome P4501B1 (CYP1B1) gene are a predominant cause of congenital glaucoma. In this study we identify CYP1B1 mutations in PCG patients.
###end p 2
###begin title 3
Methods
###end title 3
###begin p 4
###xml 88 94 88 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 27 35 <span type="species:ncbi:9606">patients</span>
Twenty-three unrelated PCG patients and 50 healthy controls were enrolled in the study. CYP1B1 was screened for mutations by PCR and DNA sequencing.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 612 618 612 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 707 713 707 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 401 409 <span type="species:ncbi:9606">patients</span>
###xml 527 535 <span type="species:ncbi:9606">patients</span>
###xml 598 606 <span type="species:ncbi:9606">patients</span>
###xml 685 693 <span type="species:ncbi:9606">patients</span>
DNA sequencing revealed a total of 15 mutations. Out of these, four (p.I94X, p.H279D, p.Q340H, and p.K433K) were novel mutations and five were known pathogenic mutations. Five coding single nucleotide polymorphisms and one intronic single nucleotide polymorphism () were also found. Truncating mutations (p.I94X and p.R355X) were associated with the most severe disease phenotype. It is possible that patients with two null alleles with no catalytic activity may present with a more severe phenotype of the disease compared to patients with one null allele (heterozygous). The disease phenotype of patients with CYP1B1 mutations was more severe compared with the clinical phenotype of patients negative for CYP1B1 mutations.
###end p 6
###begin title 7
Conclusion
###end title 7
###begin p 8
###xml 13 19 13 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 53 61 <span type="species:ncbi:9606">patients</span>
###xml 165 173 <span type="species:ncbi:9606">patients</span>
Mutations in CYP1B1 are a major cause for PCG in our patients. Identifying mutations in subjects at risk of developing glaucoma, particularly among relatives of PCG patients, is of clinical significance. These developments may help in reducing the disease frequency in familial cases. Such studies will be of benefit in the identification of pathogenic mutations in different populations and will enable us to develop simple and rapid diagnostic tests for analyzing such cases.
###end p 8
###begin title 9
Introduction
###end title 9
###begin p 10
###xml 346 347 346 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 1119 1120 1119 1120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 1121 1122 1121 1122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
Primary congenital glaucoma (PCG; OMIM ) is an autosomal recessive disorder of the eye. In this disease the trabecular meshwork (TM) and anterior chamber of the eye are affected, leading to impairment in the aqueous drainage, increased intraocular pressure (IOP), and optic nerve damage. PCG occurs during the neonatal or early infantile period [1]. The term PCG is reserved for those cases in which the only anatomic defect observed is isolated trabeculodysgenesis. This increased IOP results in ocular enlargement (buphthalmos), corneal clouding, and rapid optic nerve cupping. Progressive degeneration of the retinal ganglion cells (RGCs) results in the characteristic optic nerve atrophy and visual field defects found in glaucoma. Most cases of PCG are sporadic, but familial cases have also been reported. PCG is the most common type of pediatric glaucoma and accounts for 55% of such cases. Its expression and penetrance vary from 40-100%. Its incidence varies substantially from one population to another. It is estimated to occur in 1 in 10,000 births in Europe and 1 in 3,300 births in Andhra Pradesh, India [2,3].
###end p 10
###begin p 11
###xml 117 118 117 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 351 352 351 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
###xml 485 486 485 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
###xml 514 515 514 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 581 587 581 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 685 686 685 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 761 767 761 767 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 866 867 866 867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 868 870 868 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 995 996 995 996 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 997 998 997 998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
Recently a putative PCG locus, GLC3A, was linked to markers on the short arm of chromosome 2 in 11 Turkish families [4]. Six other families did not show linkage to this locus, suggesting locus heterogeneity for this disease. Another PCG locus, GLC3B, was localized on chromosome 1p36 in some families but did not show linkage to chromosome 2 markers [5]. Other subsets of families that did not show linkage to these two loci provide evidence for at least a third of the unmapped loci [5]. Recently Stoilov et al. [6] identified three different mutations in the cytochrome P4501B1 (CYP1B1) gene in five unrelated Turkish families in which the disease had been linked to the 2p21 locus [6]. Even though three different loci have been mapped for PCG, mutations in CYP1B1 (GLC3A) are the most predominant cause of disease and are reported in various ethnic backgrounds [6-15]. Further, it is estimated that all the known loci/genes of glaucoma account for a minority of the total cases of glaucoma [4,5], and hence many other genes remain to be identified.
###end p 11
###begin p 12
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 100 106 100 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 304 306 304 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 629 631 629 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 961 963 961 963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 964 966 964 966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 1022 1028 1022 1028 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 1065 1073 <span type="species:ncbi:9606">patients</span>
CYP1B1 is located on chromosome 2 and consists of three exons and two introns. The coding region of CYP1B1 starts at the 5' end of exon 2 and ends within exon 3. It codes for a 543-amino acid protein and is expressed in the ocular tissues, such as the anterior chamber, and in several nonocular tissues [16]. CYP1B1 is a member of the cytochrome P450 superfamily of drug-metabolizing enzymes. It catalyzes several oxidative reactions, some of which are biosynthetic, producing necessary hormones or compounds of intermediary metabolism in most living organisms and substrates, including many xenobiotics, vitamins, and steroids [17]. CYP1B1 also metabolizes vitamin A in two steps to all-trans-retinal and all-trans-retinoic acid. The latter is a potent morphogen and regulates in utero development of tissue growth and differentiation. CYP1B1 is involved in the metabolism of endogenous and exogenous substrates that take part in early ocular differentiation [18-20]. In the present study we screened all coding exons of CYP1B1 in 23 unrelated congenital glaucoma patients.
###end p 12
###begin title 13
Methods
###end title 13
###begin title 14
###xml 24 31 <span type="species:ncbi:9606">patient</span>
Clinical evaluation and patient selection
###end title 14
###begin p 15
###xml 1307 1314 1307 1308 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#176;</sup>
###xml 154 162 <span type="species:ncbi:9606">patients</span>
###xml 525 533 <span type="species:ncbi:9606">patients</span>
###xml 1178 1186 <span type="species:ncbi:9606">patients</span>
Primary congenital glaucoma cases presenting at the Dr. R. P. Centre for Ophthalmic Sciences (AIIMS, New Delhi, India), were enrolled for this study. Six patients were female and 17 were male. Mean age of presentation was 15.17 months (range 1.5 - 132 months). After ethical approval of the Institutional Review Board (IRB00006862; All India Institute of Medical Sciences, New Delhi, India), 23 PCG cases were enrolled in this study. The diagnosis involved clinical ocular and systemic examination. Inclusion criteria of the patients were increased corneal diameter (>12.0 mm) and raised IOP (>21 mmHg) with presence/absence of Haab's striae and optic disc changes (where examination was possible). Symptoms of epiphora and photophobia were the additional inclusion factors. The age of onset ranged from birth to 3 years. Detailed family histories up to three generations were taken, and pedigree charts were constructed. The history of ocular or other hereditary disorders was recorded. Glaucoma cases other than PCG were excluded. Fifty ethnically matched normal individuals without any ocular disorders were enrolled as controls. Peripheral blood samples were collected from patients and controls by venipuncture after informed consent. Blood samples were collected in EDTA vaccutainer and stored in -80 degreesC until DNA isolation.
###end p 15
###begin title 16
Mutation screening and sequence analysis
###end title 16
###begin p 17
###xml 142 148 142 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 262 269 262 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 272 273 272 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 274 276 274 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 324 326 324 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 353 355 353 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 387 389 387 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 670 671 654 655 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 801 808 781 782 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#176;</sup>
###xml 832 839 806 807 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#176;</sup>
###xml 867 874 835 836 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#176;</sup>
###xml 877 879 839 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 155 163 <span type="species:ncbi:9606">patients</span>
Genomic DNA was isolated from peripheral blood by the phenol chloroform method. The entire coding region, including exon-intron boundaries of CYP1B1, from patients and controls was amplified and screened for mutations by using three sets of overlapping primers (Table 1) [7,21]. The primers used were set I (1F-1R, 786 bp) [12], set II (2F-2R, 787 bp) [13], and set III (3F-3R, 885 bp) [12]. PCR amplifications for primer sets I and II were performed in a 40 microl volume containing 1.0 microl of 20 microM stock solution for each primer, 100 ng of genomic DNA, 1 unit of Taq polymerase (Banglore Genei), 0.1 mM of each dNTP, 4 microl of 10X PCR buffer (with 15 mM MgCl2) and 4 microl of dimethyl sulphoxide (Sigma), by means of 35 cycles of amplification, each consisting of 30 s denaturation at 94 degreesC, 30 s annealing at 56 degreesC and 1 min extension at 72 degreesC [12], while conditions for set III were initial denaturation at 94 degreesC for 3 min followed by 30 cycles each at 94 degreesC for 30 s, 60 degreesC for 30 s, and 72 degreesC for 1 min.
###end p 17
###begin title 18
The primers used for PCR amplification.
###end title 18
###begin p 19
###xml 291 297 291 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
Amplified PCR products were purified using a gel/PCR DNA fragments extraction kit (number DF100; Geneaid Biotech Ltd., Sijhih City, Taiwan). Purified PCR products were sent for sequencing to  (Molecular Cloning Laboratories, South San Francisco, CA). DNA sequences were analyzed against the CYP1B1 reference sequence  using  (multiple sequence alignment program for DNA; European Molecular Biology Laboratory (EMBL) - European Bioinformatics Institute (EBI)).
###end p 19
###begin title 20
Computational assessment of missense mutations
###end title 20
###begin p 21
###xml 476 478 476 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 479 481 479 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 975 977 975 977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 978 980 978 980 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r28">28</xref>
###xml 114 119 <span type="species:ncbi:9606">Women</span>
Two homology-based programs  (polymorphism phenotyping; Division of Genetics, Department of Medicine, Brigham and Women's Hospital/Harvard Medical School, Boston, MA) and  (sorting intolerant from tolerant; the J. Craig Venter Institute  and ) were used to predict the functional impact of missense changes identified in this study.  structurally analyzes an amino acid polymorphism and predicts whether that amino acid change is likely to be deleterious to protein function [22-24]. The prediction is based on the position-specific independent counts (PSIC) score derived from multiple sequence alignments of observations.  scores of >2.0 indicate the polymorphism is probably damaging to protein function. Scores of 1.5-2.0 are possibly damaging, and scores of <1.5 are likely benign.  is a sequence homology-based tool that sorts intolerant from tolerant amino acid substitutions and predicts whether an amino acid substitution in a protein will have a phenotypic effect [25-28].  is based on the premise that protein evolution is correlated with protein function. Positions important for function should be conserved in an alignment of the protein family, whereas unimportant positions should appear diverse in an alignment. Positions with normalized probabilities <0.05 are predicted to be deleterious and those >/=0.05 are predicted to be tolerated.
###end p 21
###begin title 22
Results
###end title 22
###begin p 23
###xml 275 281 275 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
All cases were found to be sporadic in origin. A total of 15 nucleotide changes were observed in this study. Out of these, five were previously reported coding single nucleotide polymorphisms (SNPs) and one was already reported as an intronic SNP; five were known pathogenic CYP1B1 mutations. Four novel nucleotide changes (two nonsynonymous, one frameshift, and one synonymous mutation) were also found in this study. Details of all nucleotide changes are presented below.
###end p 23
###begin title 24
Identification of four novel mutations
###end title 24
###begin title 25
Isoleucine94stop (p.I94X) mutation
###end title 25
###begin p 26
###xml 53 61 53 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
###xml 371 378 <span type="species:ncbi:9606">patient</span>
###xml 380 383 <span type="species:ncbi:9606">P55</span>
In this mutation a single base guanine (G) deletion (Figure 1) was observed at genomic position 38302285, coding nucleotide number c.247. This caused a frameshift after codon 82 and introduced a stop codon (TAG) at position 94 in the protein. This mutation produced a truncated CYP1B1 protein of 93 amino acids. This change was identified as a homozygous mutation in the patient (P55).
###end p 26
###begin p 27
###xml 29 35 29 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 70 71 70 71 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 127 128 127 128 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 172 179 <span type="species:ncbi:9606">patient</span>
###xml 180 183 <span type="species:ncbi:9606">P55</span>
DNA sequence chromatogram of CYP1B1 exon 2 equivalent to codon 81-85. A: The reference sequence derived from control is shown. B: Sequence derived from congenital glaucoma patient P55 shows the homozygous deletion of G at c.247, which caused a p.asp83thrfsX12 (p.I94X) mutation.
###end p 27
###begin title 28
Histidine279aspartic acid (p.H279D) mutation
###end title 28
###begin p 29
###xml 63 71 63 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2</xref>
###xml 335 342 <span type="species:ncbi:9606">patient</span>
###xml 344 347 <span type="species:ncbi:9606">P61</span>
In this mutation a single base cytosine (C) was replaced by G (Figure 2) at genomic position 38301697, coding nucleotide number c.835. This resulted in a codon change from CAC to GAC and an amino acid change from histidine to aspartic acid (p.H279D), a nonsynonymous mutation in the CYP1B1 protein. This mutation was identified in one patient (P61) and was heterozygous.
###end p 29
###begin p 30
###xml 29 35 29 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 72 74 72 74 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> A</bold>
###xml 130 131 130 131 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 175 182 <span type="species:ncbi:9606">patient</span>
###xml 183 186 <span type="species:ncbi:9606">P55</span>
DNA sequence chromatogram of CYP1B1 exon 2 equivalent to codon 277-280.  A: The reference sequence derived from control is shown. B: Sequence derived from congenital glaucoma patient P55 shows heterozygous c.835C>G, which predicts a codon change of CAC>GAC and a p.H279D mutation.
###end p 30
###begin title 31
Glutamine340histidine (p.Q340H) mutation
###end title 31
###begin p 32
###xml 62 70 62 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3</xref>
###xml 331 338 <span type="species:ncbi:9606">patient</span>
###xml 340 343 <span type="species:ncbi:9606">P56</span>
###xml 412 419 <span type="species:ncbi:9606">patient</span>
In this mutation a single base G was replaced by thymine (T) (Figure 3) at genomic position 38301512, coding nucleotide number c.1020. This resulted in a codon change from CAG to CAT and an amino acid change from glutamine to histidine (p.Q340H), a nonsynonymous mutation in the CYP1B1 protein. This mutation was identified in one patient (P56) and was heterozygous and present with the p.R390H mutation in this patient.
###end p 32
###begin p 33
###xml 29 35 29 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 72 73 72 73 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 129 130 129 130 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 174 181 <span type="species:ncbi:9606">patient</span>
###xml 182 185 <span type="species:ncbi:9606">P56</span>
DNA sequence chromatogram of CYP1B1 exon 2 equivalent to codon 339-342. A: The reference sequence derived from control is shown. B: Sequence derived from congenital glaucoma patient P56 shows heterozygous c.1020G>T change, which predicts a codon change CAG>CAT and heterozygous p.Q340H mutation.
###end p 33
###begin title 34
Lysine433lysine (p.K433K) mutation
###end title 34
###begin p 35
###xml 64 72 64 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f4">Figure 4</xref>
###xml 273 280 <span type="species:ncbi:9606">patient</span>
In this mutation a single base G was replaced with adenine (A) (Figure 4) at genomic position 38298198, coding nucleotide number c.1299. This resulted in a codon change from AAG to AAA and resulted in no amino acid change (lysine). This was a neutral mutation (p.K433K) in patient P69.
###end p 35
###begin p 36
###xml 29 35 29 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 72 73 72 73 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 129 130 129 130 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 174 181 <span type="species:ncbi:9606">patient</span>
DNA sequence chromatogram of CYP1B1 exon 3 equivalent to codon 431-434. A: The reference sequence derived from control is shown. B: Sequence derived from congenital glaucoma patient P69 shows heterozygous c.1294C>G and heterozygous c.1299G>A, which predicts codon change CTG>GTG and AAG>AAA and heterozygous p.L432V and p.K433K mutations, respectively.
###end p 36
###begin p 37
All four novel mutations p.I94X, p.H279D, p.Q340H, and p.K433K have been registered in GenBank with accession numbers , , , and , respectively.
###end p 37
###begin title 38
###xml 37 43 37 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
Other previously reported pathogenic CYP1B1 mutations
###end title 38
###begin title 39
Glutamic acid229lysine (p.E229K) mutation
###end title 39
###begin p 40
###xml 305 312 <span type="species:ncbi:9606">patient</span>
###xml 314 317 <span type="species:ncbi:9606">P65</span>
This mutation resulted in G being replaced with A at genomic position 38301847 (), coding nucleotide number c.685. This resulted in a codon change from GAA to AAA and an amino acid change from glutamic acid to lysine (p.E229K), a nonsynonymous mutation in the CYP1B1 protein. This change was found in one patient (P65) and was heterozygous.
###end p 40
###begin title 41
Arginine355stop (p.A355X) mutation
###end title 41
###begin p 42
###xml 52 60 52 60 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f5">Figure 5</xref>
###xml 355 357 355 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r29">29</xref>
###xml 394 401 <span type="species:ncbi:9606">patient</span>
###xml 403 406 <span type="species:ncbi:9606">P70</span>
In this mutation a single base C was replaced by T (Figure 5) at genomic position 38298434, coding nucleotide number c.1063. This resulted in a codon change from CGA to TGA (p.R355X), a nonsense mutation in the CYP1B1 protein. This resulted in a truncated CYP1B1 protein of 355 amino acids. The p.R355X mutation was described only once in the literature [29]. This change was homozygous in one patient (P70).
###end p 42
###begin p 43
###xml 29 35 29 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 72 74 72 74 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> A</bold>
###xml 130 131 130 131 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 175 182 <span type="species:ncbi:9606">patient</span>
###xml 183 186 <span type="species:ncbi:9606">P70</span>
DNA sequence chromatogram of CYP1B1 exon 3 equivalent to codon 353-356.  A: The reference sequence derived from control is shown. B: Sequence derived from congenital glaucoma patient P70 shows homozygous c.1063C>T, which predicts a codon change CGA>TGA and p.R355X nonsense mutation.
###end p 43
###begin title 44
Arginine368histidine (p.R368H) mutation
###end title 44
###begin p 45
###xml 288 295 <span type="species:ncbi:9606">patient</span>
###xml 297 300 <span type="species:ncbi:9606">P68</span>
In this mutation a single base G was replaced by A at genomic position 38298394 (), coding nucleotide number c.1103. This resulted in a codon change from CGT to CAT and an amino acid change from arginine to histidine (p.R368H), a nonsynonymous mutation. This change was homozygous in one patient (P68).
###end p 45
###begin title 46
Arginine390cysteine (p.R390C) mutation
###end title 46
###begin p 47
###xml 289 296 <span type="species:ncbi:9606">patient</span>
###xml 298 301 <span type="species:ncbi:9606">P64</span>
In this mutation a single base C was replaced by T at genomic position 38298329 (), coding nucleotide number c.1168. This resulted in a codon change from CGC to TGC and an amino acid change from arginine to cysteine (p.R390C), a nonsynonymous mutation. This mutation was identified in one patient (P64) and was heterozygous.
###end p 47
###begin title 48
Arginine390histidine (p.R390H) mutation
###end title 48
###begin p 49
###xml 52 60 52 60 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f6">Figure 6</xref>
###xml 298 305 <span type="species:ncbi:9606">patient</span>
###xml 307 310 <span type="species:ncbi:9606">P56</span>
In this mutation a single base G was replaced by A (Figure 6) at genomic position 38298328, coding nucleotide number c.1169. This resulted in a codon change from CGC to CAC and an amino acid change from arginine to histidine (p.R390H), a nonsynonymous mutation. This mutation was identified in one patient (P56) and was heterozygous.
###end p 49
###begin p 50
###xml 29 35 29 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 72 73 72 73 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 129 130 129 130 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 174 181 <span type="species:ncbi:9606">patient</span>
###xml 182 185 <span type="species:ncbi:9606">P56</span>
DNA sequence chromatogram of CYP1B1 exon 3 equivalent to codon 388-391. A: The reference sequence derived from control is shown. B: Sequence derived from congenital glaucoma patient P56 shows homozygous c.11169G>A, which predicts a codon change CGC>CAC and p.R390H mutation.
###end p 50
###begin title 51
###xml 14 20 14 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
Nonpathogenic CYP1B1 single nucleotide polymorphisms
###end title 51
###begin p 52
###xml 100 101 100 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
In addition to these pathogenic mutations, six previously reported single nucleotide polymorphisms [8] were identified in a less conserved region of the CYP1B1 protein. Details of these polymorphisms are provided below.
###end p 52
###begin title 53
Cytisine (C) to thymine (T) change in intron 1
###end title 53
###begin p 54
###xml 95 101 95 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 142 150 <span type="species:ncbi:9606">patients</span>
In this mutation, C was replaced by T at genomic position 38302544, nucleotide position 780 in CYP1B1 () in intron I. This was observed in 13 patients but was absent in controls.
###end p 54
###begin title 55
Arginine48glycine (p.R48G)
###end title 55
###begin p 56
In this mutation, C was replaced by guanine (G) at genomic position 38302390 (), coding nucleotide number c.142. This resulted in a codon change from CGG to GGG and an amino acid change from arginine to glycine (p.R48G), a nonsynonymous mutation in the CYP1B1 protein. This change was also present in controls.
###end p 56
###begin title 57
Alanine119serine (p.A119S)
###end title 57
###begin p 58
###xml 282 290 <span type="species:ncbi:9606">patients</span>
###xml 291 294 <span type="species:ncbi:9606">P55</span>
In this mutation G was replaced by T at genomic position 38302177 (), coding nucleotide number c.355. This resulted in a codon change from GCC to TCC and an amino acid change from alanine to lysine (p.A119S), a nonsynonymous mutation in the CYP1B1 protein. This change was found in patients P55 and P73 but absent in controls.
###end p 58
###begin title 59
Leucine432valine (p.L432V)
###end title 59
###begin p 60
###xml 309 317 <span type="species:ncbi:9606">patients</span>
###xml 346 354 <span type="species:ncbi:9606">patients</span>
###xml 361 364 <span type="species:ncbi:9606">P55</span>
###xml 370 373 <span type="species:ncbi:9606">P68</span>
###xml 399 406 <span type="species:ncbi:9606">patient</span>
In this mutation a single base C was replaced by G at genomic position 38298203 (), coding nucleotide number c.1294. This resulted in a codon change from CTG to GTG and an amino acid change from leucine to valine (p.L432V), a nonsynonymous mutation in the CYP1B1 protein. This mutation was identified in four patients; it was homozygous in three patients (P52, P55, and P68) and heterozygous in one patient (P69) and was also present in controls.
###end p 60
###begin title 61
Aspartic acid449aspartic acid (p.D449D)
###end title 61
###begin p 62
###xml 342 350 <span type="species:ncbi:9606">patients</span>
In this mutation a single base T was replaced by C at genomic position 38298150 (), nucleotide position 5174 in the gene, coding nucleotide number c.1347. This resulted in a codon change from GAT to GAC and no change in the amino acid (aspartic acid) (p.D449D), a synonymous mutation in the CYP1B1 protein. This mutation was identified in 20 patients and was homozygous in all. This change was also present in controls.
###end p 62
###begin title 63
Asparagine453serine (p.N453S)
###end title 63
###begin p 64
###xml 315 323 <span type="species:ncbi:9606">patients</span>
In this mutation a single base A was replaced by G at genomic position 38298139 (), coding nucleotide number c.1358. This resulted in a codon change from AAC to AGC and an amino acid change from asparagine to serine (p.N453S), a nonsynonymous mutation in the CYP1B1 protein. The p.N453S mutation was present in two patients (P51 and P62) but absent in controls.
###end p 64
###begin p 65
###xml 65 72 65 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 83 88 83 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B</italic>
###xml 172 179 172 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
###xml 234 240 234 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 293 299 293 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 349 355 349 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 530 536 530 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 799 805 799 805 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 35 43 <span type="species:ncbi:9606">patients</span>
###xml 509 517 <span type="species:ncbi:9606">patients</span>
###xml 757 760 <span type="species:ncbi:9606">P56</span>
###xml 765 768 <span type="species:ncbi:9606">P61</span>
The clinical manifestations of PCG patients have been tabulated (Table 2), and the CYP1B1 sequence variants identified in the various studies to date have been summarized (Table 3). The clinical phenotype of the cases with pathogenic CYP1B1 mutations was more severe compared to cases without CYP1B1 mutations. The mean IOP of cases with pathogenic CYP1B1 mutations was 30.21 mmHg compared to 23.96 mmHg in mutation-negative cases; the difference is significant (p value <0.005). The mean corneal diameter in patients without the CYP1B1 mutations was 12.625x12.181 mm (left eye) and 12.406x12.781 mm (right eye), whereas it was 13.833x13.750 mm (left eye) and 13.416x15.50 mm (right eye) in mutation-negative cases. Haab's striae were present in two cases (P56 and P61), which were positive for the CYP1B1 mutations.
###end p 65
###begin title 66
###xml 31 39 <span type="species:ncbi:9606">patients</span>
Clinical manifestations of PCG patients.
###end title 66
###begin p 67
Footnote: M- male; F- female; H-homozygous; h-heterozygous; X- times; Trab/Trab+MMC- combined trabeculotomy trabeculectomy and mitomycin C treatment; OD- right eye; OS- left eye; OU- both eyes; mutations in bold letters- novel mutations.
###end p 67
###begin title 68
Summary of the sequence variants identified in various studies till date.
###end title 68
###begin p 69
Footnote: PCG- Primary congenital glaucoma; POAG- Primary open angle glaucoma; PA-Peter's anomaly; FS-frameshift; X- stop codon; NA- not applicable; mutations in bold letters- novel mutations.
###end p 69
###begin title 70
Discussion
###end title 70
###begin title 71
Structural/functional implications of mutations
###end title 71
###begin title 72
p.I94X mutation
###end title 72
###begin p 73
###xml 186 194 186 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f7">Figure 7</xref>
###xml 303 304 303 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 305 307 305 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 308 310 308 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r29">29</xref>
###xml 311 313 311 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r30">30</xref>
In the isoleucine94stop mutation (p.194X) mutation a truncated protein of 93 amino acids is produced in which only the first 82 amino acids are the same as the wild-type CYP1B1 protein (Figure 7). This truncated protein lacks all functional domains of the CYP1B1 protein and is a nonfunctional protein [6,21,29,30].
###end p 73
###begin p 74
###xml 38 40 38 40 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> A</bold>
###xml 68 69 68 69 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 234 235 234 235 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
Amino acid sequence of CYP1B1 protein. A: Wild-type CYP1B1 protein. B: Truncated CYP1B1 protein of 93 amino acids (black arrow shows the position after which frameshift takes place and red letters shows amino acids after frameshift). C: Truncated CYP1B1 protein of 354 amino acids.
###end p 74
###begin title 75
p.H279D mutation
###end title 75
###begin p 76
###xml 483 491 483 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f8">Figure 8</xref>
###xml 549 557 549 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f9">Figure 9</xref>
###xml 698 705 <span type="species:ncbi:9606">patient</span>
###xml 707 710 <span type="species:ncbi:9606">P61</span>
This histidine residue lies in the carboxyl terminal of the G helix in the CYP1B1 protein. Replacement of an aromatic, weak basic, amino acid histidine whose charge state depends upon its protonation state with an aliphatic, strong acidic, and negatively charged aspartic acid at this locus. This in turn affects the local charge distribution, and hence the structure of the protein is disturbed. Histidine is conserved at this locus in the CYP1A1 protein from 12 different species (Figure 8) and in the CYP1B1 protein from seven different species (Figure 9) analyzed, suggesting that histidine performs some important functions at this locus. No other known pathogenic mutation was present in the patient (P61), and the PSIC score of this mutation was 2.628, indicating that this change is probably damaging to the protein function. The SIFT score of p.H279D was 0.00 and is predicted to be deleterious for the protein function.
###end p 76
###begin p 77
###xml 32 37 <span type="species:ncbi:9606">human</span>
###xml 160 165 <span type="species:ncbi:9606">human</span>
###xml 401 406 <span type="species:ncbi:9606">human</span>
Multi sequence alignment of the human CYP1B1 protein with the CYP1A1 protein from different species. Red Underlined amino acids shows the conserved residues in human CYP1B1 and different CYP1A1 protein from different species (when mutated) causing primary congenital glaucoma phenotype. While Red letter shows amino acid conserved in different CYP1A1 protein from different species but not present in human CYP1B1 protein.
###end p 77
###begin p 78
###xml 31 36 <span type="species:ncbi:9606">human</span>
###xml 305 314 <span type="species:ncbi:7955">Zebrafish</span>
Multisequence alignment of the human CYP1B1 protein with the CYP1B1 protein from different species. Underlined red amino acids show the conserved residues (when mutated) causing the primary congenital glaucoma phenotype. Red colored amino acid shows the non-conservation of glutamic acid at this locus in Zebrafish CYP1B1. Blue-colored amino acids show the less conserved residues in CYP1B1 protein from different species.
###end p 78
###begin title 79
p.Q340H mutation
###end title 79
###begin p 80
###xml 325 333 325 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f8">Figure 8</xref>
###xml 413 421 413 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f9">Figure 9</xref>
###xml 794 796 794 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 599 606 <span type="species:ncbi:9606">patient</span>
This glutamine residue lies in the carboxyl terminal of the I helix. Replacement of a polar uncharged amino acid (glutamine) with a weak basic amino acid (histidine) may or may not alter the structure/function of the protein. Glutamine is not conserved at this locus in the CYP1A1 protein from 12 different species analyzed (Figure 8) but is conserved in the CYP1B1 protein from seven different species analyzed (Figure 9). The PSIC score of this mutation was 0.276, indicating that this change is benign to protein function. The SIFT score of p.Q340H was 0.05 and is predicted to be tolerated. The patient with the p.Q340H mutation also had a known pathogenic CYP1B1 mutation (p.R390H) and had a PSIC score of 2.799 and a SIFT score of 0.00. The p.R390H mutation has previously been reported [21] to adversely affect or damage protein function.
###end p 80
###begin title 81
p.E229K mutation
###end title 81
###begin p 82
###xml 689 691 686 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r30">30</xref>
###xml 922 924 919 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r31">31</xref>
The p.E229k mutation occurred in the carboxyl terminal of the F helix in the vicinity of the substrate-binding region in the CYP1B1 protein. Substitution of E to K leads to a change from a negatively charged residue to a positively charged side chain, and this in turn affects the local charge distribution. This disturbs an important cluster of salt bridges. In wild-type CYP1B1 protein, R-194::E-229, R-194::D-333, and D-333::K-512 form a triangle of ionic bond interactions, holding the I helix with the F helix and beta-strand S3.2. As a result of this mutation, the R-194::E-229 interaction is lost, which has the potential to destabilize the other ionic interactions in the protein [30]. The SIFT score of the p.E229K mutation was 0.01 and is predicted to be deleterious for the protein function. The CYP1B1 protein with the p.E229K mutation shows 20-40% enzymatic activity compared to the wild-type CYP1B1 protein [31].
###end p 82
###begin title 83
p.R355X mutation
###end title 83
###begin p 84
###xml 77 85 77 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f7">Figure 7</xref>
###xml 374 375 374 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 376 378 376 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 379 381 379 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r29">29</xref>
###xml 382 384 382 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r30">30</xref>
In the p.R355X mutation, a truncated protein of 354 amino acids is produced (Figure 7). The arginine residue at position 355 lies in the carboxyl terminal of the J helix, carboyxl terminal of the J helix is involved in the functionally important heme-binding domain. This truncating mutation results in a loss of the heme-binding domain and a functionally inactive protein [6,21,29,30].
###end p 84
###begin title 85
p.R368H mutation
###end title 85
###begin p 86
###xml 73 74 73 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 75 77 75 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 748 750 748 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r31">31</xref>
This arginine residue lies between the J and K helix in an exposed loop [8,15]. In this mutation the positively charged amino acid arginine is replaced by histidine whose charge state depends upon its protonation state. Consequences of this change are not immediately apparent. In the wild type, arginine at position 368 interacts with G-365, D-367, V-363, and D-374. Because of the R368H mutation, interaction between D-367 and D-374 are weakened. The PSIC score of this mutation was 2.653, indicating that this change is probably damaging to protein function. The SIFT score of p.R368H was 0.00 and is predicted to be deleterious for the protein function. How p.R368H affects the conformation and functionality of the protein is still not clear [31].
###end p 86
###begin title 87
p.R390H/C mutation
###end title 87
###begin p 88
###xml 65 66 61 62 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 184 186 180 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
This arginine residue is located in the conserved alpha helix K [8]. It forms the consensus sequence GluXXArg, which is conserved among all members of the cytochrome P450 superfamily [21]. Arg390 and Glu387 are one helical turn apart and are predicted to form a salt bridge. The parallel orientation of their side chains is more transparent in the three-dimensional model. Conservation of this motif indicates that presence of arginine at this position is essential for the normal function of the P450 molecule. The PSIC scores of p.R390C and p.R390H were 3.474 and 2.799, respectively, indicating that both these changes are probably damaging to protein function. The SIFT score of p.R390H/C was 0.00 and is predicted to be deleterious for the protein function.
###end p 88
###begin p 89
The PSIC scores of the nonpathogenic single nucleotide polymorphisms were <2 for p.R48G, p.A119S, p.N453S, and p.L432V, indicating that all these changes were benign to protein function. The SIFT scores of the nonpathogenic single nucleotide polymorphisms were >0.05 for p.R48G, p.L432V, p.K433K, and p.D449D, indicating that all these changes were tolerated in the protein.
###end p 89
###begin p 90
###xml 143 149 143 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 216 222 216 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 296 297 296 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 249 257 <span type="species:ncbi:9606">patients</span>
PCG is a clinically and genetically heterogeneous disorder. More than 50 different mutations have been reported in the entire coding region of CYP1B1 from various populations. We screened the entire coding region of CYP1B1 in 23 congenital glaucoma patients by using primers described elsewhere [8]. Of all mutations identified herein, the frameshift mutation (c.247delG) and nonsense mutation (c.1063C>T) resulted in the most severe disease phenotype.
###end p 90
###begin p 91
###xml 765 771 765 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 849 855 849 855 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 4 11 <span type="species:ncbi:9606">patient</span>
###xml 13 16 <span type="species:ncbi:9606">P55</span>
###xml 66 71 <span type="species:ncbi:9606">child</span>
The patient (P55) with the p.I94X (homozygous) mutation is a male child of a consanguineous marriage without any family history of glaucoma; he presented at 8 months of age. He was born at full term through a normal vaginal delivery. He had severe bilateral corneal edema at birth. At the age of 2 months he had congestion with discharge in the left eye and was diagnosed to have a left corneal ulcer and was treated with antibiotics; the left eye consequently developed phthisis. The right eye dimensions increased, and he was diagnosed as having buphthalmos at the age of 8 months. Combined trabeculotomy and trabeculectomy with mitomycin C was performed in his right eye. He was diagnosed as having 100% blindness at 8 months. His parents were also screened for CYP1B1 mutations by DNA sequencing but were found to be negative for any pathogenic CYP1B1 mutations.
###end p 91
###begin p 92
###xml 559 565 559 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
###xml 8 11 <span type="species:ncbi:9606">P70</span>
###xml 620 623 <span type="species:ncbi:9606">P55</span>
###xml 628 631 <span type="species:ncbi:9606">P70</span>
Patient P70 has a p.R355X (homozygous) mutation and is a male offspring of a non-consanguineous marriage; he presented at 45 days. At birth, he had bilateral congenital glaucoma and had IOPs of 30 and 40 mmHg in his left and right eye, respectively. He had severe corneal clouding in both eyes, at birth, and therefore the fundus was not visualized. Combined trabeculotomy and trabeculectomy with mitomycin C was performed in both eyes. He had no light perception and was visually blind since 45 days of age. His parents were also negative for the pathogenic CYP1B1 mutations. The absence of mutations in the parents of P55 and P70 could be due to a parental germline mutation, which cannot be tested by using peripheral leukocytes.
###end p 92
###begin p 93
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
###xml 8 11 <span type="species:ncbi:9606">P56</span>
###xml 24 29 <span type="species:ncbi:9606">child</span>
Patient P56 is a female child of a non-consanguineous marriage; she presented at the age of 1 year. She has p.Q340H (heterozygous) and p. R390H (homozygous) mutations. She had bilateral congenital glaucoma since birth. She had a corneal diameter of 14.0x14.0 mm (right eye) and 14.5x14.5 mm (left eye) and IOPs of 28 and 30 mmHg in the right and left eye, respectively. She had Haab's striae in both eyes, and the fundus was not visible. Combined trabeculotomy and trabeculectomy with mitomycin C was performed in both eyes.
###end p 93
###begin p 94
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
###xml 8 11 <span type="species:ncbi:9606">P61</span>
###xml 22 27 <span type="species:ncbi:9606">child</span>
Patient P61 is a male child of a non-consanguineous marriage; he presented at the age of 4 months and has a p.H279D (heterozygous) mutation. He had bilateral congenital glaucoma at birth. At presentation corneal diameter and IOPs of his left and right eye were 15.5x15.0 mm and 14.0x14.0 mm and 30 mmHg and 34 mmHg, respectively. The cup to disc ratio of the left eye was not visible due to the hazy media and that of the right eye was 0.9:1. He had Haab's striae in both eyes. Combined trabeculotomy and trabeculectomy with mitomycin C was performed in both eyes.
###end p 94
###begin p 95
###xml 130 136 130 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 208 209 208 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 210 212 210 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r29">29</xref>
###xml 397 398 397 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 399 401 399 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r32">32</xref>
###xml 421 427 421 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 585 591 585 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 770 776 770 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 781 786 781 786 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FOXC1</italic>
###xml 921 923 921 923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r33">33</xref>
###xml 1038 1044 1038 1044 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 153 161 <span type="species:ncbi:9606">patients</span>
###xml 277 285 <span type="species:ncbi:9606">patients</span>
###xml 387 395 <span type="species:ncbi:9606">patients</span>
###xml 514 522 <span type="species:ncbi:9606">patients</span>
An intriguing finding that apparently does not match a typical recessive pattern of inheritance is the presence of a heterozygous CYP1B1 mutation in PCG patients. This situation has been previously reported [7,29]. A heterozygous p.Y81N mutation has also been described in PCG patients from Germany, and a heterozygous p.E229K mutation has been identified in unrelated French and Indian patients [7,32]. Few heterozygous CYP1B1 mutations were associated with the milder, primary, open-angle glaucoma phenotypes in patients from Spain, France, and India. The presence of a heterozygous CYP1B1 mutation in PCG suggests the possibility of other loci, yet undetected, that may be involved in anterior chamber formation. Recently the presence of double heterozygote variants CYP1B1 and FOXC1 has been described in two PCG cases, although the role of possible digenic inheritance in disease causation is yet to be established [33]. Defective variants of modifier genes and/or environmental factors have an additive effect with loss-of-function CYP1B1 alleles to produce the disease phenotype. However further work is required to understand this mechanism.
###end p 95
###begin p 96
###xml 82 88 82 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 135 141 135 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 153 155 153 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r34">34</xref>
###xml 392 398 392 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 533 539 533 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 632 638 632 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 650 657 650 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 915 921 915 921 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 1012 1018 1012 1018 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 68 76 <span type="species:ncbi:9606">patients</span>
###xml 118 126 <span type="species:ncbi:9606">patients</span>
###xml 200 208 <span type="species:ncbi:9606">patients</span>
###xml 276 284 <span type="species:ncbi:9606">patients</span>
###xml 317 325 <span type="species:ncbi:9606">patients</span>
###xml 478 486 <span type="species:ncbi:9606">patients</span>
###xml 488 491 <span type="species:ncbi:9606">P55</span>
###xml 493 496 <span type="species:ncbi:9606">P56</span>
###xml 498 501 <span type="species:ncbi:9606">P61</span>
###xml 503 506 <span type="species:ncbi:9606">P68</span>
###xml 512 515 <span type="species:ncbi:9606">P70</span>
###xml 579 587 <span type="species:ncbi:9606">patients</span>
###xml 589 592 <span type="species:ncbi:9606">P64</span>
###xml 597 600 <span type="species:ncbi:9606">P65</span>
###xml 680 688 <span type="species:ncbi:9606">patients</span>
###xml 806 814 <span type="species:ncbi:9606">patients</span>
###xml 877 885 <span type="species:ncbi:9606">patients</span>
###xml 986 994 <span type="species:ncbi:9606">patients</span>
Previous studies have reported that the age of disease onset in PCG patients with CYP1B1 mutations is younger than in patients without CYP1B1 mutations [34]. Our data show that the onset age in three patients (P60, P66, and P67) was 7, 3, and 11 months, while the rest of the patients presented at birth. In these 20 patients there is no significant difference in the age of disease onset in CYP1B1 mutation-positive and mutation-negative cases, although clinical phenotypes of patients (P55, P56, P61, P68, and P70) with homozygous CYP1B1 mutations were more severe compared to patients (P64 and P65) who were heterozygous for the CYP1B1 mutations (Table 1). It is possible that patients with two null alleles with no catalytic activity may present with a more severe phenotype of the disease compared to patients with one null (heterozygote) allele. The disease phenotype of patients with homozygous/heterozygous CYP1B1 mutations was more severe compared to the clinical phenotype of patients negative for the CYP1B1 mutations.
###end p 96
###begin p 97
###xml 63 69 63 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 160 166 160 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 375 377 375 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 590 592 590 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 593 595 593 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 596 598 596 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r29">29</xref>
###xml 1534 1535 1534 1535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 49 57 <span type="species:ncbi:9606">patients</span>
###xml 604 611 <span type="species:ncbi:9606">patient</span>
###xml 612 615 <span type="species:ncbi:9606">P55</span>
###xml 806 813 <span type="species:ncbi:9606">patient</span>
###xml 938 945 <span type="species:ncbi:9606">patient</span>
###xml 947 950 <span type="species:ncbi:9606">P70</span>
###xml 1161 1168 <span type="species:ncbi:9606">Patient</span>
###xml 1169 1172 <span type="species:ncbi:9606">P61</span>
We also observed a higher mean IOP in a group of patients with CYP1B1 mutations. In accordance with the idea of associating the severe phenotypes with the null CYP1B1 allele, the percentage of severe phenotypes in at least one eye has been reported to be associated with various mutations ranging 80-100% for a frameshift mutation (e.g., c.376insA) and truncating mutations [11]. Three different truncation mutations (p.C280X, p.E281X, and p.R355X) producing a truncated protein of 279, 280, and 354 amino acids, respectively, have also been associated with more severe disease phenotypes [11,21,29]. In patient P55 with a homozygous p.I94X mutation, a truncated protein of 93 amino acids is produced that has the first 82 amino acids similar to the wild-type CYP1B1 protein. The disease phenotype of this patient is severe with a left phthisic and a right buphthalmic eye with a cup to disc ratio of 0.9:1. He is visually blind. Another patient (P70) with a p.R355X mutation had bilateral buphthalmos with severe corneal edema and a corneal diameter of 15.0x15.0 mm and 15.0x14.5 mm in the left and right eye, respectively. He was blind at the age of 45 days. Patient P61 with a p.H279D mutation had bilateral buphthalmos with mild edema in both eyes and a corneal diameter of 15.5x15.5 mm and 14.0x14.0 mm in the left and right eye, respectively. He was blind at the age of 4 months. The range of percentages of severe phenotypes in at least one eye is 62-83% for different mutations, such as p.G61E, p.E229K, p.R368H, and p.R390C [9].
###end p 97
###begin p 98
###xml 423 425 423 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 809 811 809 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 812 814 812 814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
Membrane-bound cytochromes, such as CYP1B1, have a molecular structure containing a transmembrane domain located at the N-terminal end of the molecule. This is followed by a proline-rich "hinge" region, which permits flexibility between the membrane-spanning domain and the cytoplasmic portion of the protein molecule. The COOH-terminal ends are highly conserved among different members of the cytochrome P450 superfamily [17]. This family contains a set of conserved core structures responsible for the heme-binding region of these molecules. The heme-binding region is essential for the normal function of every P450 molecule. Between the hinge region and the conserved core structure lies a less conserved substrate-binding region. The cytochrome P450 protein functions like any classical enzyme molecule [18,19]. Mutations affecting such enzymes generally produce recessive phenotypes because in heterozygous subjects the normal allele is capable of compensating for the mutant allele. Mutations in the CYP1B1protein interfere with the integrity of the CYP1B1 protein as well as its ability to adopt a normal conformation and to bind heme; for example, induced mutations in the hinge region have previously been reported to interfere with the heme-binding properties of the cytochrome P450 molecules
###end p 98
###begin p 99
###xml 18 24 18 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 97 98 97 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 99 101 99 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 102 104 102 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r35">35</xref>
###xml 105 107 105 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r37">37</xref>
###xml 255 256 255 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 478 484 478 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 597 605 <span type="species:ncbi:9606">patients</span>
###xml 848 855 <span type="species:ncbi:9606">patient</span>
Thus mutations of CYP1B1 are a major cause of PCG in our study as well as various other studies [6-15,35-37]. This study confirms genetic heterogeneity of the disease. We identified four novel mutations in this study in addition to one previous reported [7]. Studies of pathogenic sequence variants of CYP1B1 in different populations will contribute to a better understanding of the pathogenesis of PCG and will aid in analyzing the structure-function relationship of different CYP1B1 mutations Identifying mutations in subjects at risk of developing glaucoma, particularly among relatives of PCG patients, is of clinical significance. Monitoring vision in these families would be helpful. These developments may help in reducing the disease frequency in familial cases. Such studies will also help in understanding the pathogenic mutations in our patient populations and enable us to develop simple and rapid diagnostic tests for analyzing such cases. This may lead to the development of novel therapies in the management of congenital glaucoma.
###end p 99
###begin title 100
Acknowledgments
###end title 100
###begin p 101
###xml 141 149 <span type="species:ncbi:9606">patients</span>
This work was financially supported by Department of Biotechnology, Government of India. The authors would like to thank the families of the patients for their cooperation without this study was not possible. The author Mukesh Tanwar thanks University Grants Commission (UGC), Govt. of India for providing Senior Research Fellowship (SRF).
###end p 101
###begin title 102
References
###end title 102
###begin article-title 103
Primary infantile glaucoma (congenital glaucoma).
###end article-title 103
###begin article-title 104
Congenital glaucoma and its inheritance.
###end article-title 104
###begin article-title 105
Population-based assessment of childhood blindness in southern India.
###end article-title 105
###begin article-title 106
Assignment of a locus (GLC3A) for primary congenital glaucoma (buphthalmos) to 2p21and evidence for genetic heterogeneity.
###end article-title 106
###begin article-title 107
A second locus (GLC3B) for primary congenital glaucoma (buphthalmos) maps to the 1p36 region.
###end article-title 107
###begin article-title 108
Identification of three different truncating mutations in cytochrome P450B1 (CYP1B1) as the principal cause of primary congenital glaucoma (buphthalmos) in families linked to the GLC3A locus on chromosome 2p21.
###end article-title 108
###begin article-title 109
###xml 64 72 <span type="species:ncbi:9606">patients</span>
Mutation spectrum of CYP1B1 in north Indian Congenital glaucoma patients.
###end article-title 109
###begin article-title 110
Identification of novel mutations causing familial primary congenital glaucoma in Indian pedigrees.
###end article-title 110
###begin article-title 111
###xml 50 58 <span type="species:ncbi:9606">Patients</span>
Correlations of Genotype with Phenotype in Indian Patients with Primary Congenital Glaucoma.
###end article-title 111
###begin article-title 112
Molecular genetics of primary congenital glaucoma in Brazil.
###end article-title 112
###begin article-title 113
###xml 62 70 <span type="species:ncbi:9606">patients</span>
Novel Cytochrome p.4501B1 (CYP1B1) gene mutations in Japanese patients with Primary Congenital Glaucoma.
###end article-title 113
###begin article-title 114
###xml 44 52 <span type="species:ncbi:9606">patients</span>
Novel cytochrome P450 (CYP1B1) mutations in patients with primary congenital glaucoma in France.
###end article-title 114
###begin article-title 115
Mutations in CYP1B1, the gene for cytochrome P4501B1, are the predominant cause of primary congenital glaucoma in Saudi Arabia.
###end article-title 115
###begin article-title 116
Identification of a single ancestral CYP1B1 mutation in Slovak gypsies (Roms) affected with primary congenital glaucoma.
###end article-title 116
###begin article-title 117
Multiple CYP1B1 mutations and incomplete penetrance in an inbred population segregating primary congenital glaucoma suggest frequent de novoevents and a dominant modifier locus.
###end article-title 117
###begin article-title 118
###xml 28 33 <span type="species:ncbi:9606">Human</span>
Complete cDNA Sequence of a Human Dioxin-inducible mRNA Identifies a New Gene Subfamily of Cytochrome P450 That Maps to Chromosome 2.
###end article-title 118
###begin article-title 119
###xml 110 117 <span type="species:ncbi:4097">tobacco</span>
###xml 142 147 <span type="species:ncbi:9606">human</span>
Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes.
###end article-title 119
###begin article-title 120
###xml 79 84 <span type="species:ncbi:9606">human</span>
Biosynthesis of all trans-retinol: catalysis of all-trans-retinol oxidation by human p-450 cytochrome.
###end article-title 120
###begin article-title 121
Retinoid metabolizing enzymes in development.
###end article-title 121
###begin article-title 122
Proposed role of drug-metabolizing enzymes: regulation of steady state levels of the ligands that affect growth, homeostasis, differentiation and neuroendocrine functions.
###end article-title 122
###begin article-title 123
Sequence analysis and homology modeling suggest that primary congenital glaucoma on 2p21 results from mutations disrupting either the hinge region or the conserved core structures of cytochrome P4501B1.
###end article-title 123
###begin article-title 124
###xml 46 51 <span type="species:ncbi:9606">human</span>
Kondrashiv, Bork P. Prediction of deleterious human alleles.
###end article-title 124
###begin article-title 125
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human non-synonymous SNPs: server and survey.
###end article-title 125
###begin article-title 126
###xml 30 35 <span type="species:ncbi:9606">human</span>
Towards a structural basis of human non-synonymous single nucleotide polymorphisms.
###end article-title 126
###begin article-title 127
Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm.
###end article-title 127
###begin article-title 128
SIFT: predicting amino acid changes that affect protein function.
###end article-title 128
###begin article-title 129
Rajasekaran R, Sudandiradoss C, Ramanathan K, Purohit R, Sethumadhavan R. A novel computational and structural analysis of nsSNPs in CFTR gene.
###end article-title 129
###begin article-title 130
###xml 52 57 <span type="species:ncbi:9606">human</span>
The characterisation and functional analysis of the human glyoxalase-1 gene using methods of bioinformatics.
###end article-title 130
###begin article-title 131
Primary congenital glaucoma: three case reports on novel mutations and combinations of mutations in the GLC3A (CYP1B1) gene.
###end article-title 131
###begin article-title 132
Characterization of biochemical and structural phenotypes of four CYP1B1 mutations observed in individuals with primary congenital glaucoma.
###end article-title 132
###begin article-title 133
###xml 28 36 <span type="species:ncbi:9606">patients</span>
CYP1B1 mutations in Spanish patients with primary congenital glaucoma: phenotypic and functional variability.
###end article-title 133
###begin article-title 134
###xml 27 35 <span type="species:ncbi:9606">patients</span>
CYP1B1 mutations in French patients with early-onset primary open-angle glaucoma.
###end article-title 134
###begin article-title 135
The transcription factor gene FOXC1 exhibits a limited role in primary congenital glaucoma.
###end article-title 135
###begin article-title 136
###xml 67 75 <span type="species:ncbi:9606">patients</span>
Phenotype of cytochrome P450B1 gene (CYP1B1) mutations in Japanese patients with primary congenital glaucoma.
###end article-title 136
###begin article-title 137
###xml 22 28 22 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 38 46 <span type="species:ncbi:9606">patients</span>
Molecular analysis of CYP1B1 in Omani patients with primary congenital glaucoma: a pilot study.
###end article-title 137
###begin article-title 138
###xml 62 70 <span type="species:ncbi:9606">patients</span>
CYP1B1 gene analysis in primary congenital glaucoma Brazilian patients: Novel mutations and association with poor prognosis.
###end article-title 138
###begin article-title 139
Cytochrome P4501B1 mutations cause only part of primary congenital glaucoma in Ecuador.
###end article-title 139

